P rostaglandin (PG)E 2 and PGE 1 play principal roles in maintaining the patency of the ductus arteriosus (DA) during gestation. PGE 1 is widely used to keep the DA open in patients with DA-dependent congenital heart diseases, because both PGE 1 and PGE 2 increase the intracellular concentration of cAMP, resulting in vasodilation in the DA. 1, 2 On the other hand, we have demonstrated that PGE-EP4-cAMP signals during late gestation increased hyaluronan production in the DA and consequently induced intimal thickening (IT), which is critical for permanent closure of the DA after birth. 3 Therefore, the effects of PGE 1/2 on vasodilation and remodeling oppose each other in terms of regulation of the DA after birth. Differential regulation of vasodilation and IT in the DA would be preferable for patients who need PGE/anti-PGE therapy.
Because intracellular cAMP is synthesized by adenylyl cyclases (ACs), which are transmembrane enzymes activated by G protein-coupled receptors, including PGE receptors, ACs must play an important role in regulating vasodilation and remodeling in the DA. To date, nine different isoforms of membrane-bound forms of ACs (AC1 through AC9) have been identified in vertebrate tissues. 4 Most tissues express several AC isoforms, which exhibit remarkable diversities in their biochemical properties. 5, 6 Because smooth muscle cells (SMCs) in the DA exert biological properties distinct from SMCs in other vessels such as the aorta, we hypothesized that such properties are attributable, at least in part, to the distinct roles of specific AC isoforms in the DA.
In addition to the role of PGE 1/2 in vasodilation, the PGE-AC-cAMP signal cascade has been shown to regulate vascular remodeling. 7, 8 For example, cAMP markedly inhibits proliferation of SMCs 9 and reduces IT after arterial injury in vivo, 10 a process that shares many aspects with IT in the DA. 1, 11 Interestingly, several studies have demonstrated that PGE 1/2 inhibits the proliferation of vascular SMCs, 7, 8 whereas others have reported that PGE 2 stimulates the growth of vascular SMCs. 12, 13 Such diversities in the effects of PGE signaling might be related to differential expression of AC isoforms among vascular tissues. It has been difficult, however, to evaluate the contribution of ACs to relevant phenomena in an AC isoform-dependent manner, because multiple isoforms of ACs are coexpressed. This is partially attributable to the lack of available AC isoform-selective pharmacological regulators. In previous studies, we synthesized more than 200 new derivatives of forskolin (a non-isoform-selective AC activator) and identified derivatives that are selective to specific AC isoforms. 6, 14, 15 Such AC isoform-selective activators enable us to explore the role of each AC isoform in vascular tone and remodeling especially in vivo. In the present study, using such AC isoform-specific activators, overexpression or selective silencing of AC isoforms and AC-isoform deficient-mice, we have investigated the role of AC isoforms and the availability of AC isoform-selective activators in regulating DA vascular tone and remodeling.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Reagents
Forskolin derivatives: 6-[N-(2-isothiocyanatoethyl) aminocarbonyl] forskolin (FD1), 14, 16 and 6-[3-(dimethylamino)propionyl]-14,15dihydroforskolin (FD6) 14 were kindly provided by Nippon Kayaku Co, Ltd (Tokyo, Japan).
Animals and Tissues
All animals were cared for in compliance with the guiding principles of the American Physiological Society. The experiments were approved by the ethical committee of animal experiments at Yokohama City University School of Medicine. Wistar rat embryos were obtained from timed-pregnant mothers (Japan SLC Inc, Shizuoka, Japan). Pooled tissues of DA and aorta were obtained from rat embryos on embryonic day (E)19 (nϾ60) and E21 (nϾ60) and neonates on the day of birth (day0, nϾ60). Generation and phenotypes of AC5 knockout mice (AC5KO) and AC6 knockout mice (AC6KO) have been described previously. 17, 18 All mice were littermates from heterozygote crosses.
Isolation and Culture of Rat Ductus Arteriosus Smooth Muscle Cells
Vascular SMCs were obtained from DA and aorta of Wistar rat embryos at E21 as previously described. 19 
Quantitative and Semiquantitative RT-PCR
Isolation of total RNA and generation of cDNA were performed and RT-PCR analysis was done as previously described. 19 The primers were designed based on the rat nucleotide sequences of AC isoforms. Table  I ), and PCR products were confirmed by sequencing. The abundance of each gene was determined relative to the GAPDH transcript using TaqMan Rodent GAPDH control reagents kits (Applied Biosystems, Foster City, Calif).
Each primer set was designed between multiple exons (Online

Immunoblot Analysis
Proteins from whole cells were analyzed by immunoblotting as previously described. 19 
RNA Interference
Double-stranded small interfering (si)RNAs to the selected regions of AC2-7 and the negative siRNA used as a control were purchased from QIAGEN (Hilden, Germany) or Invitrogen (San Diego, Calif) (Online Table II ). According to the instructions of the manufacturer, cells were transfected with siRNA (300 pmol), using Lipofectamin RNAiMAX (Invitrogen).
Adenovirus Construction
Full-length cDNA-encoding rat AC2 was cloned into the shuttle vector for construction of an adenoviral vector harboring AC2 through the use of an AdenoX adenovirus construction kit (Clontech, Tokyo, Japan). Adenovirus encoding murine AC6 driven by a cytomegalovirus promoter was generated by homologous recombination as previously described. 20 Adenovirus encoding MKK3 was kindly provided by Dr Yibin Wang (University of California, Los Angeles). 21
cAMP Production by Radioimmunoassay
Rat ductus arteriosus smooth muscle cells (DASMCs) were serumstarved for 48 hour and assayed for cAMP production by RIA after incubation with drugs of interest (Online Data Supplement).
Quantitation of Hyaluronan
The amount of hyaluronan in the cell culture supernatant was measured by the latex agglutination method as previously described. 3
Organ Culture
DA organ culture was performed as previously described. 3, 22 
Measurement of Isometric Tension of the Vascular Rings of DA
Isometric tension of the vascular rings of DA was measured as previously described. 23 
Non-standard Abbreviations and Acronyms
Rapid Whole-Body Freezing Method
To study the in situ morphology and inner diameter of neonatal DA, a rapid whole-body freezing method was used as previously described. 24 The fetuses at E21 were delivered by cesarean section and intraperitoneally injected 1 hour after birth with PGE 1 , FD1 or FD6 in 200 L of saline. The minimal dose of FD1 (10.8 mg/kg of body weight) and FD6 (1.29 mg/kg of body weight) that caused maximal dilation in the DA were used.
Protein Kinase A Activity
Protein kinase (PK)A activity was measured using an assay kit (StressGen Biotechnologies, Ann Arbor, Mich) according to the instructions of the manufacturer, as described previously. 25
Statistical Analysis
Data are shown as the meansϮSEM of independent experiments. Statistical analysis was performed between two groups by unpaired Student t test or between multi-groups by one-way ANOVA followed by Student-Newman-Keuls multiple comparison test. A value of PϽ0.05 was considered significant.
Results
Multiple Transcripts of AC Isoforms in Rat DA
First, we detected all isoforms except for AC1 and AC8 in rat E21 DA by semiquantitative analyses ( Figure 1A ). Next, quantitative RT-PCR analyses of AC2-7 showed that AC2, AC5, and AC6 were abundantly expressed in rat DA and that the expression levels of AC2 and AC6 were significantly higher in the DA than in the aorta during the perinatal period, whereas those of AC5 were comparable between the DA and the aorta. The expression of AC2 reached maximal level in E21 DA ( Figure 1B ), whereas that of AC6 was increased during development in rat DA ( Figure 1C ).
AC6 Is Responsible for Hyaluronan Production in DASMCs
We examined the contribution of AC2, AC5 and AC6 to PGE 1 -induced cAMP production in DASMCs by using AC2-, AC5-, and AC6-targeted siRNAs. The expression levels of ACs mRNAs using the siRNAs are shown in Online Figure I. Silencing of AC5 or AC6 dramatically decreased PGE 1induced cAMP production and that of AC2 also decreased PGE 1 -induced cAMP production by 58% (Figure 2A ), indicating that AC2, AC5 and AC6 are major isoforms responsible for cAMP production by PGE 1 in DASMCs. We then examined the effect of ACs on hyaluronan production in DASMCs. AC6-targeted siRNA weakened PGE 1 -induced hyaluronan production, whereas AC2-, and AC5-targeted siRNA did not ( Figure 2B ). Neither AC3-, AC4-, nor AC7targeted siRNA weakened PGE 1 -induced hyaluronan production (Online Figure II) . Using adenovirus-mediated gene transfer of AC2 and AC6 (Adv.AC2 and Adv.AC6), efficacy of which is shown in Online Figure III , we found that the overexpression of AC6, but not of AC2, further enhanced PGE 1 -induced hyaluronan production when compared with the overexpression of LacZ as a control ( Figure 2C ). Interestingly, co-overexpression of both AC2 and AC6 negated AC6-mediated enhancement of hyaluronan production.
AC6 Gene Transfer, but Not AC2, Promoted IT in Rat DA Explants
When AC6 was overexpressed in immature rat DA explants in which IT had not yet formed, prominent IT with strong hyaluronan deposition was observed in AC6-overexpressed DA explants, as compared to LacZ controls ( Figure 3A , 3B, and 3D). The internal lumen of the DA treated with Adv.AC6 was almost completely closed ( Figure 3C ). However, overexpression of AC2 did not promote hyaluronan deposition and IT formation. Further, Adv.AC2 abrogated AC6 overexpressioninduced hyaluronan production and IT ex vivo, which is consistent with the data in Figure 2C . Taken together, these results indicate that AC2 has an inhibitory effect on AC6-induced hyaluronan-mediated IT in DA explants.
AC6 Deficiency Decreased IT in Mouse DA
Although AC5 and AC6 share an extremely high amino acid homology, the above experiments suggested that AC6 is a major isoform for DA remodeling. We therefore examined whether AC6 indeed plays a major role in in vivo IT of the DA and found that genetic disruption of the AC6 isoform resulted in less IT during late gestation (E18.5) ( Figure 4B , 4D, and 4F). It should be noted that DAs closed after birth in AC6KO mice (data not shown). The IT of AC5KO mice was normally developed at E18.5 ( Figure 4A , 4C, and 4E), and the DA of AC5KO mice closed after birth (data not shown). These findings support the conclusion that AC6 plays a primary role in IT and, thus, the vascular remodeling in the mouse DA.
Effect of Isoform-Selective AC Activators on cAMP Accumulation in Rat DASMCs
Based on the findings of previous crystallographic studies and computer-assisted drug design, we identified forskolin derivatives (FD1 or FD6) that have enhanced selectivity for AC2 or AC5 in regulating tissue AC catalytic activity. 14 However, the ability of cAMP production via AC6 of FD1 and FD6 has not been demonstrated. FD1 enhanced LacZ control-induced cAMP accumulation in DASMCs infected with Adv.AC2 or Adv.AC6 ( Figure 5A ). FD6 enhanced cAMP accumulation in DASMCs with Adv.AC6, but not with Adv.AC2. These data suggest that FD1 stimulates both AC2 and AC6 and that FD6 stimulates AC5 and AC6. We confirmed that FD1 (AC2/6 stimulator) and FD6 (AC5/6 stimulator) increased cAMP accumulation in DASMCs in a dose-dependent manner ( Figure 5B ).
The Effects of Isoform-Selective AC Activators on DASMC Hyaluronan Production
We then found that FD6 significantly increased hyaluronan production ( Figure 5C ) and transcripts of hyaluronan synthase type 2 (HAS2) in DASMCs at 10 Ϫ5 mol/L ( Figure 5D ). In contrast, FD1, in doses up to 10 Ϫ5.5 mol/L, did not increase hyaluronan production or HAS2 transcripts up. It should be noted that production of cAMP by FD1 at a concentration of 10 Ϫ5.5 mol/L was equivalent to that by FD6 at 10 Ϫ5 mol/L ( Figure 5B and 5C) and that FD1 significantly decreased DASMC viability at a concentration higher than 10 Ϫ5 mol/L. Silencing of AC6, but not of AC5, abolished FD6-induced hyaluronan production ( Figure 5E ), indicating that AC6 is responsible for FD6-induced hyaluronan production. Furthermore, to examine whether the effect of FD6 on hyaluronan production is specific to DASMCs, we found that FD6 did not induce hyaluronan production in SMCs from the rat aorta ( Figure 5F ), because expression of AC6 mRNA in aortic SMCs was approximately 60% lower than in DASMCs. However, when AC6 was overexpressed in the aortic SMCs, hyaluronan production was significantly increased by 1.4Ϯ0.1-fold (nϭ6) in the presence of FD6 (10 Ϫ5 mol/L), suggesting that this data can provide insight into a more general vascular remodeling by AC6.
Involvement of MKK3-p38 MAPK in AC6-Induced Hyaluronan Production
To examine the mechanism by which AC2 inhibits AC6induced hyaluronan production, we focused on several signal pathways such as p38 mitogen-activated protein kinase (MAPK). We found that FD6 increased phosphorylation of p38 protein in DASMCs, whereas FD1 and N6-Benzoyladenosine-cAMP (Bnz-cAMP), a PKA selective cAMP analog, did not ( Figure 6A and 6B ). FD6-induced phosphorylation of p38 and MKK3/6 was negated in DASMCs treated with AC6-targeted siRNA ( Figure 6C ). FD1 increased phosphorylation of p38 and MKK3/6 when AC2 expression was downregulated by AC2-targeted siRNA ( Figure 6C ). FD6induced hyaluronan production was attenuated by SB203580, a p38 inhibitor, or H89, a PKA inhibitor. Combined treatment of SB203580 and H89 further inhibited hyaluronan production ( Figure 6D ). In contrast, SB203580 did not affect PKA-induced hyaluronan production ( Figure 6E ). These data suggest that p38 MAPK and PKA independently regulate hyaluronan production. Furthermore, overexpression of MKK3, the efficacy of which is demonstrated by Adv.MKK3 ( Figure 6F ), enhanced FD6-induced hyaluronan production in DASMCs ( Figure 6G ). Extracellular signal-related kinase (ERK)1/2 and c-Jun N-terminal kinase (JNK) were not phosphorylated by FD6 (data not shown). Phospholipase C, PKC, IP3 receptor, PI3-kinase, and Epac signaling were not involved in AC6-induced hyaluronan production, as shown using specific agonists or inhibitors for each pathway (Online Figure IV) . These data indicate that stimulation of AC6 promotes hyaluronan production via both p38 and PKA pathways and that AC2 inhibits the AC6-activated MKK3-p38 pathway.
The Effects of Isoform-Selective AC Activators on IT Ex Vivo
We then examined the effects on FD1 and FD6 on IT using DA explants. Consistent with other data (Figures 5 and 6) , 48 hour incubation with FD6 significantly induced IT, increased hyaluronan production, and narrowed the internal lumen in DA explants (Figure 7 ). It should be noted that FD1 and FD6, similarly to forskolin and PGE 1 , inhibited proliferation of DASMCs. Overexpression of AC2 or AC6 also inhibited DNA synthesis in DASMCs (Online Figure V) , indicating that FD6 does not directly promote IT by proliferation of DASMCs.
The Effects of Isoform-Selective AC Activators on Vasodilation
Because PGE 1/2 strongly dilates the DA via activation of ACs, AC activators should be potent vasodilators for the DA as well. We found that FD1 and FD6 similarly attenuated indomethacin-induced contraction in DA explants ( Figure  8A ). We then examined the vasodilatory effect of FD1 and FD6 in vivo using a whole-body freezing method. Here, the DA closed completely 1 hour after birth ( Figure 8B ) when PGE 1 , FD1, or FD6 were administrated by intraperitoneal injection. Consistent with previous data, 24 PGE 1 caused maximal dilatation 30 minutes after injection and then the DA completely closed within 2 hour ( Figure 8C and 8D ). FD1 induced maximal dilatation of the DA up to 4 hour and then the DA gradually contracted, suggesting that FD1 has a longer vasodilatory effect on the DA than dose PGE 1 . Although FD6 also dilated the DA 30 minutes after injection, all neonates died approximately 4 hours after injection because of suppression of respiration, which is the same side effect caused by PGE 1 and was not caused by FD1. We also found that FD1 and FD6 did not affect the diameter of the ascending aorta, whereas FD6, but not FD1, significantly dilated the main pulmonary artery up to 4 hour after administration (Online Figure VI , A through C). Using cultured DASMCs, AC6-targeted siRNA attenuated forskolin-induced phosphorylation of vasodilator-stimulated phosphoprotein (VASP), whereas AC2-targeted siRNA had no effect, suggesting that AC6 is primarily involved in DA vasodilation (Online Figure VI, D) . Taken together, these results reveal that AC6 play a primary role in hyaluronan-mediated vascular remodeling in the DA through activation of the PKA and MKK3-p38 MAPK pathways and that AC2 has an inhibitory effect on AC6-mediated hyaluronan production and IT.
Discussion
The Effect of AC2, AC5, and AC6 on Vascular Remodeling
The present study demonstrated for the first time that AC plays a significant role in vascular remodeling in the DA. Intimal thickening during development is a critical form of vascular remodeling for postnatal closure of the DA. 3, 26 We found that hyaluronan induced by PGE-EP4-cAMP signaling is a prominent constituent of the extracellular matrix of IT in the DA. 3 It seems a worthwhile endeavor to investigate mechanisms leading to an increase in hyaluronan, because insights into its regulatory mechanisms and signaling pathways might eventually lead to ways of controlling hyaluronan-mediated IT in the DA. However, the isoformselective role of AC in DA vascular remodeling has not previously been reported. Importantly, we found that AC6 is responsible for hyaluronan-mediated IT in the DA via activation of the MKK3-p38 and PKA pathways and that AC2 has an inhibitory effect on AC6-mediated hyaluronan production and DA remodeling. We also demonstrated that simultaneous stimulation of AC2 and AC6 by FD1 produces a longer vasodilatory effect than does PGE 1 without inducing hyaluronan-mediated IT.
It is important to identify whether the source of hyaluronan is from SMCs or endothelial cells of the DA. Using cell sorting analysis, we found that the expression levels of HAS1, HAS2 and AC6 mRNAs in CD31-positive/CD45negative endothelial cells from E21 rat DA were significantly lower than those in CD31-negative/CD45-negative SMCs from E21 rat DA (Online Figure VII) . Therefore, we believe that DASMCs are a major source of hyaluronan production.
DA IT in AC6-Deficient Mice
Our results also showed that the DA of AC6KO mice had less fully formed IT during late gestation. These results support the belief that AC6 plays a role in EP4-mediated hyaluronan synthesis. Nevertheless, the DA of AC6KO mice eventually closed after birth, similarly to wild-type mice, whereas the DA remained open in EP4KO mice. These results suggest Figure 5 . The effects of FD1 and FD6 on cAMP and hyaluronan production in DASMCs. A, Effect of overexpression of AC2 or AC6 on FD1-or FD6-induced cAMP accumulation (nϭ6). B, FD1 and FD6 increased cAMP accumulation in DASMCs in a dose-dependent manner (nϭ4). C, FD6, but not FD1, increased hyaluronan production (nϭ8 to 11). D, FD6 significantly increased HAS2 mRNA (nϭ6). E, AC6-targeted siRNA negated FD6-induced hyaluronan production (nϭ4). F, FD6, PGE 1 , and forskolin did not induce hyaluronan production in aortic SMCs (nϭ6). **PϽ0.01 and ***PϽ0.001 vs control (CTRL). Fsk indicates forskolin.
that other AC isoforms might compensate for deficiency of AC6. Alternatively, other EP4 signal pathways in addition to the AC-cAMP pathway may be involved in the patency of EP4KO mice. Further study is required to determine how multiple signaling pathways contribute to yield IT in the DA. We assume that the closure of the DA in AC6KO mice may be delayed after birth because of insufficient IT, which will also be addressed in our future studies.
Interaction of AC2 and AC6 Signaling in Hyaluronan-Mediated IT
AC isoforms have specific patterns of regulation by G proteins, protein kinases and calcium/calmodulin. For example, cAMP production by AC2 is stimulated by several signals including G s -␣ and ␤␥-subunits, and by PKC. In contrast, cAMP production by AC6 is only stimulated by G s -␣ and inhibited by G i -␣, PKA, and low concentrations of Ca 2ϩ . 4, 27 Moreover, different AC isoforms have different effects on cAMP-mediated responses independent of their rate of synthesis of cAMP. 28 To the best of our knowledge, this is the first study to show how the effect of an AC isoform counteracts the effect of another isoform independent of cAMP production. We demonstrated that overexpression of AC2 by itself has little effect on hyaluronan production and appears to have an inhibitory effect on AC6induced hyaluronan and IT. These data are consistent with the other experiments in which activation of both AC2 and AC6 by FD1 did not induce hyaluronan and IT in DASMCs and DA explants. The response of FD6 to hyaluronan production was much greater than that of FD1, even though FD6 produced less cAMP than FD1 at the same concentrations, suggesting that this process is not simply dependent on the amount of intracellular cAMP.
The next important question is the mechanism how AC2 and AC6 differentially regulate vascular remodeling of the DA. Our results demonstrated that AC6 induced hyaluronan production via the MKK3-p38 MAPK and PKA pathways and that AC2 inhibited the MKK3-p38 pathway, resulting in inhibition of AC6-induced hyaluronan production. PKC, phospholipase C, PI3-kinase, Epac, and other MAPK pathways including ERK and JNK were not involved in AC6-induced hyaluronan production. In addition, we also found that AC2 is primarily localized in the caveolae fraction, whereas AC5/6 localized in the caveolae and the noncaveolae fractions (Online Figure VIII) . This differential localization may change the effect of AC2 and AC6 on the downstream signal pathways. Identification of the upstream target linking AC6 and the MKK3-p38 pathways will be addressed in future studies. 
Clinical Implications of Using AC Isoform-Selective Modulations
The manipulation of the contractile state of the DA is important for patients with patent DA and complicated congenital heart diseases. All currently available pharmacological therapies rely on synthetic PGE 1 to dilate the DA and prostaglandin H synthase inhibitors to close it. Because these therapies basically change the plasma and/or local concentra- 10) . B, The whole-body freezing method revealed that the rat DA opened widely after birth and closed 1 hour after birth (arrow) (nϭ5). C, Representative images of rat DAs treated with PGE 1 and FD1 using the whole-body freezing method. D, The vasodilating effects of PGE 1 , FD1, or FD6 were compared (nϭ5 to 7). FD1 had a longer action of duration than did PGE 1 . All rats injected with FD6 died 4 hours after injection because of apnea. Bars: 1 mm. PA indicates pulmonary artery. tion of PGE, they broadly affect the contractile state and the cellular responses in other types of smooth muscle and tissues, resulting in severe adverse effects on systemic organs. Moreover, PGE 1 has a short duration of action and induces hyaluronan-mediated IT in the DA. In cases of DA-dependent congenital heart diseases, opening of the DA without induction of IT is of particular necessity until the hemodynamics can be improved through surgery. Although differential regulation of vasodilation and IT is preferable for treatment of patients with DA-dependent congenital cardiac malformations, such a treatment is not currently available. Therefore, selective manipulation should be a desirable direction for novel therapeutic strategies. In the present study, we demonstrated that AC isoform-selective activators differentially regulated vascular tone and remodeling in the DA. Our data imply that AC2/6-selective manipulation could be a novel means of achieving DA vasodilation with only minimal effects on the pulmonary arteries and aorta. Moreover, the AC2/6 activator, FD1 has longer pharmacological effects than does PGE 1 . Recent studies from other authors have indicated that specific agonists/antagonists for EP4 specifically regulate ductal prostaglandin signals, 29 which could potentially yield a DA-selective vasodilator or vasoconstrictor. However, it should be noted that the EP4 receptor underwent short-term agonist-induced desensitization, 30 which is a common biological phenomenon involving reduction of responsiveness despite continuous agonist induction. Direct activation of AC may overcome the disadvantages of agonist-induced desensitization and FD1 may be beneficial for patients with DA-dependent congenital heart diseases.
In conclusion, we have shown that AC2 and AC6 exert distinct regulation of vascular tone and play an important role in DA remodeling. AC isoform-selective pharmacotherapy using FD1 may serve as a novel therapeutic strategy for patients with DA-dependent congenital heart diseases and as an alternative to currently available PGE therapy.
